Home Appointments CEO
CEO
CVS Health
| Appointee | Karen Lynch |
|---|---|
| Role | CEO |
| Organisation | CVS Health |
| Domain | Corporate Leadership |
| Start | 1 February 2021 |
| End | 17 October 2024 |
| Notes | First woman CEO of CVS Health (largest Fortune 500 firm led by a woman) |
Institutional context
CVS Health Corporation is a US healthcare and retail-pharmacy conglomerate, the largest by revenue in 2020 (and intermittently the largest in subsequent years). Its constituent businesses include CVS Pharmacy, Aetna (acquired 2018), and Caremark. From the merger formation in 2018 through February 2021 every CEO was male.
Career path
Karen S. Lynch (born 1963) earned a BS in business administration from Boston College. She held progressively senior positions at Cigna and at Magellan Health Services, then joined Aetna in 2012 as President of Specialty Products and was named President of Aetna in 2015. Following the CVS-Aetna merger in 2018 she served as Executive Vice President of CVS Health and President of Aetna.
Appointment
CVS Health announced her selection as CEO on 12 November 2020, effective 1 February 2021. She succeeded Larry Merlo. She is the first woman CEO of CVS Health and the first to lead a Fortune 5 company.
Tenure
Three years and eight months. Tenure included CVS Health's expansion into primary-care delivery through the Signify Health and Oak Street Health acquisitions in 2022 and 2023, substantial COVID-19 vaccine and testing operations through CVS Pharmacy, and a contested cost-management programme. She left the CEO role on 17 October 2024 and was succeeded by David Joyner.
Cluster context
Lynch's February 2021 appointment is part of the dataset's second corporate-leadership wave (2020-2021). Her tenure — at the largest Fortune 500 firm to have had a woman CEO at the time — represented an institutional-scale first that was widely cited in subsequent corporate-governance discussion.